NYSE MKT LLC · XTNT
-2.14% · -$0.0100 · Vol 207.1K
Market closed · last close 4:00 PM ET · price as of 20:00:00 ET
Xtant Medical Holdings Inc

Xtant Medical Holdings Inc

Health Care
$0.3200
Card
Relationship Map

Follow $XTNT

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $XTNT by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Analyst data unavailable at compute time · Sentiment absence reason unknown
XTNT
Xtant Medical Holdings Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

36/ 100
Veridion Score
Lower range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: LOW · 4 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is XTNT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading XTNT catalysts
About Xtant Medical Holdings Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2007
Employees
151
Country
US

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.3330
Day high
$0.3333
Day low
$0.3200
Previous close
$0.3270
52W high
$0.9200
-65.22% from high
52W low
$0.3050
2% of range
Market cap
$45.9M
P/E
9.76×
EPS
$-0.0600
Beta
0.95
Shares out
140.3M
Volume
207.1K
0.06× rel vol
Avg volume
3.5M
VWAP
$0.3229
Price history computed in-house
1W
-7.46%
1M
-3.99%
3M
-27.37%
1Y
-50.76%
YTD
-59.18%
SMA 50 $0.3830 · below
SMA 200 $0.5210 · below
52W position 2%

XTNT overview

Loading financial statements
Loading XTNT Form 4 filings
Public disclosures

Congress activity in XTNT

No receipt-qualified Congressional disclosure is present for XTNT in the cached public ledger.

Federal contracts

XTNT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for XTNT in this window.
Lobbying spend

XTNT lobbying filings, year to date.

Registered lobbying filings matched to Xtant Medical Holdings Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for XTNT in this window.
Loading news for XTNT
Analyst ratings
Sovereign unlock shows live analyst consensus for XTNT.
Options
Sovereign unlock shows live options positioning for XTNT.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.